归脾汤加减联合艾司唑仑片治疗心脾两虚型围绝经期失眠临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R256.23

基金项目:


Clinical Study on Modified Guipi Decoction Combined with Esazolam Tablets for Perimenopausal Insomnia of Dual Deficiency of the Heart-Spleen Type
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察归脾汤加减联合艾司唑仑片治疗心脾两虚型围绝经期失眠的临床疗效。方法:按随机 数字表法将60例心脾两虚型围绝经期失眠患者分为对照组和治疗组各30例。对照组给予艾司唑仑片治疗,治 疗组在对照组基础上联合归脾汤加减治疗。比较2组治疗前后中医证候评分,匹兹堡睡眠质量指数(PSQI)、 性激素水平[雌二醇(E2)、促黄体生成素(LH) 和促卵泡激素(FSH)] 水平,分析其临床疗效与不良反应 情况。结果:治疗组总有效率为96.67%,对照组为76.67%,2组比较,差异有统计学意义(P<0.05)。治疗 后,2组多梦易醒、心悸、健忘、头晕目眩等中医证候评分均较治疗前降低(P<0.05),且治疗组上述各项评 分均低于对照组(P<0.05)。治疗后2组睡眠质量、入睡时间、睡眠时间、睡眠效率、睡眠障碍、催眠药物、 日间功能障碍等PSQI 各维度评分及总分均较治疗前降低(P<0.05),且治疗组上述各项评分均低于对照 组(P<0.05)。治疗后,2组血清E2水平较治疗前升高(P<0.05),LH、FSH水平较治疗前降低(P<0.05); 且治疗组E2 水平高于对照组(P<0.05),LH、FSH 水平低于对照组(P<0.05)。治疗组不良反应发生率为 3.33%,对照组为20.00%,2组比较,差异有统计学意义(P<0.05)。结论:归脾汤加减联合艾司唑仑片治疗 心脾两虚型围绝经期失眠疗效显著,可改善患者中医证候和睡眠质量,调节性激素水平,且不良反应相对 较少。

    Abstract:

    Abstract: Objective: To observe the clinical effect of modified Guipi Decoction combined with Esazolam Tablets for perimenopausal insomnia of dual deficiency of the heart-spleen type. Methods: A total of 60 cases of patients with perimenopausal insomnia of dual deficiency of the heart-spleen type were divided into the control group and the treatment group according to the random number table method,with 30 cases in each group. The control group was treated with Esazolam Tablets,and the treatment group was additionally treated with modified Guipi Decoction on the basis of the control group. Traditional Chinese medicine (TCM) syndrome scores,Pittsburgh Sleep Quality Index (PSQI) and sex hormone levels [estradiol (E2), luteinizing hormone (LH) and follicle-stimulating hormone (FSH)] before and after treatment were compared between the two groups; clinical effects and incidence of adverse reactions were analyzed. Results:The total effective rate was 96.67% in the treatment group and 76.67% in the control group,the difference being significant (P<0.05). After treatment, the scores of TCM syndromes such as profuse dreaming and restless sleep, palpitation, forgetfulness and dizziness in the two groups were decreased when compared with those before treatment (P<0.05),and the scores above in the treatment group were lower than those in the control group (P<0.05). After treatment, PSQI scores of sleep quality, time of falling asleep,sleep time,sleep efficiency,sleep disorders,hypnotic drugs,daytime dys function,etc., and the total PSQI scores in the two groups were decreased when compared with those before treatment (P<0.05), and the above scores in the treatment group were lower than those in the control group (P< 0.05). After treatment, serum E2 levels in the two groups were increased when compared with those before treatment (P<0.05), and the levels of LH and FSH were decreased when compared with those before treatment (P<0.05);the level of E2 in the treatment group was higher than that in the control group (P<0.05),and the levels of LH and FSH in the treatment group were lower than those in the control group (P<0.05). The incidence of adverse reactions was 3.33% in the treatment group and 20.00% in the control group, the difference being significant (P<0.05). Conclusion: Modified Guipi Decoction combined with Esazolam Tablets has a significant effect in the treatment of perimenopausal insomnia of dual deficiency of the heart-spleen type,which can improve TCM syndromes and sleep quality and regulate the levels of sex hormones,with relatively few adverse reactions.

    参考文献
    相似文献
    引证文献
引用本文

陈波.归脾汤加减联合艾司唑仑片治疗心脾两虚型围绝经期失眠临床研究[J].新中医,2024,56(14):30-34

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-07-28
  • 出版日期:
文章二维码